4Patel A, ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus ( the ADVANCE trim ) :a randomised controlled trial[ J ]. Lancet ,2007, 370(9590) :829 -840.
5Cooper-DeHoff RM, INVEST Investigators. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients-findings from the Intematiortal Verapamil SR./Trandolapril Study (INVEST) [ J]. Am Heart J,2006,151 (5) : 1072 - 1079.
6Viberti G, Wheeldon NM, MicroAlbuminuria Reduction With VAL- sartan (MARVAL) Study Investigators. Micrealbuminuria reduction with valsartan in patients with type 2 diabetes mellitus : a blood pressure-independent effect [ J ]. Circulation, 2002,106 ( 6 ) : 672 - 678.
7Andre. VALUE : analysis of results[J]. Lancet ,2004,364 (9438) : 932 - 933.
8The ALLHAT officer and coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor a calcium channel blocker vs diuretice - the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [J]. JAMA, 2002, 288 ( 23 ) :2981 - 2977.
9Duncan J Campbell. A review of perindopril in the reduction of cardiovascular events [ J ]. Vase Health Risk Manag,2006,2 ( 2 ) : 117 - 124.
10ONTARGET Inveatigators, Yusuf S, Teo KK, et al. Telmisartan, ramipril,or both in patients at high risk for vascular events[J]. N Engl J Med ,2008,358 ( 15 ) : 1547 - 1559.
2Teba Alnima,Peter W. de Leeuw,Frans E.S. Tan,Abraham A. Kroon.Renal Responses to Long-Term Carotid Baroreflex Activation Therapy in Patients With Drug-Resistant Hypertension[J]. Hypertension . 2013 (6)
3Yuji,Yoshitomi,Ken-ichi,Kawanishi,Akihisa,et al.Effectiveness of the direct renin inhibitor,aliskiren,in patients with resistant hypertension. International Heart Journal . 2013
